GB0304494D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0304494D0
GB0304494D0 GBGB0304494.8A GB0304494A GB0304494D0 GB 0304494 D0 GB0304494 D0 GB 0304494D0 GB 0304494 A GB0304494 A GB 0304494A GB 0304494 D0 GB0304494 D0 GB 0304494D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0304494.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0304494.8A priority Critical patent/GB0304494D0/en
Publication of GB0304494D0 publication Critical patent/GB0304494D0/en
Priority to PCT/EP2004/002021 priority patent/WO2004076415A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0304494.8A 2003-02-27 2003-02-27 Compounds Ceased GB0304494D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0304494.8A GB0304494D0 (en) 2003-02-27 2003-02-27 Compounds
PCT/EP2004/002021 WO2004076415A1 (en) 2003-02-27 2004-02-25 1- (hetero)aroyl-pyrrolidine-2-carboxylic acid derivatives useful as anti.viral agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0304494.8A GB0304494D0 (en) 2003-02-27 2003-02-27 Compounds

Publications (1)

Publication Number Publication Date
GB0304494D0 true GB0304494D0 (en) 2003-04-02

Family

ID=9953773

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0304494.8A Ceased GB0304494D0 (en) 2003-02-27 2003-02-27 Compounds

Country Status (2)

Country Link
GB (1) GB0304494D0 (en)
WO (1) WO2004076415A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2292126T3 (en) * 2004-03-26 2008-03-01 Smithkline Beecham Corporation USED 4-CARBOXIPIRAZOL DERIVATIVES AS ANTIVIRAL AGENTS.
WO2008137126A2 (en) 2007-05-04 2008-11-13 Vertex Pharmaceuticals Incorporated Combination therapy for the treatment of hcv infection
US9034970B2 (en) 2009-08-11 2015-05-19 Johns Manville Curable fiberglass binder comprising salt of inorganic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713502B2 (en) * 2000-05-05 2004-03-30 Smithkline Beecham Corporation Anti-infectives
GB0216985D0 (en) * 2002-07-22 2002-08-28 Glaxo Group Ltd Compounds
KR20050057670A (en) * 2002-10-24 2005-06-16 글락소 그룹 리미티드 1-acyl-pyrrolidine derivatives for the treatment of viral infections

Also Published As

Publication number Publication date
WO2004076415A1 (en) 2004-09-10

Similar Documents

Publication Publication Date Title
GB0309781D0 (en) Compounds
GB0316915D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
EP1689403A4 (en) Heteroaryl-hydrazone compounds
GB0304665D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0313914D0 (en) Compounds
EP1658301A4 (en) N-desmethyl-n-substituted-11-deoxyerythromycin compounds
EP1682514A4 (en) 11- o-methylgeldanamycin compounds
GB0304494D0 (en) Compounds
GB0302512D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0304492D0 (en) Compounds
GB0314477D0 (en) Compounds
GB0305721D0 (en) Compounds
GB0305717D0 (en) Compounds
GB0316865D0 (en) Compounds
GB0310066D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)